MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Melanoma and MAPK Pathways
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

749 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
749 works in the cohort · of 4,299,418page 2 of 15

Labels cover 2 of 749 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 749 of 749 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Updated overall survival (OS) results for BRIM-3, a phase III randomized, open-label, multicenter trial comparing BRAF inhibitor vemurafenib (vem) with dacarbazine (DTIC) in previously untreated patients with <i>BRAF<sup>V600E</sup></i>-mutated melanoma.
Paul B. Chapman, Axel Hauschild, Caroline Robert, James Larkin, John B.A.G. Haanen, Antoni Ribas +14 more
2012· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
140
citations
affunlabeled
Molecular biology of normal melanocytes and melanoma cells
Bizhan Bandarchi, Cyrus Aleksandre Jabbari, Ali Vedadi, Roya Navab
2013· review· en· Journal of Clinical Pathology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
136
citations
afffundno abstractunlabeled
Defining the role of the RSK isoforms in cancer
Thibault Houlès, Philippe P. Roux
2017· review· en· Seminars in Cancer Biology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
126
citations
affno abstractunlabeled
AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade
F. Donelson Smith, Lorene K. Langeberg, Cristina Cellurale, Tony Pawson, Deborah K. Morrison, Roger J. Davis +1 more
2010· article· en· Nature Cell Biology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
125
citations
affno abstractunlabeled
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
Paolo A. Ascierto, Daniil Stroyakovskiy, Helen Gogas, Caroline Robert, Karl D. Lewis, Светлана Проценко +13 more
2022· article· en· The Lancet Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
104
citations
venueno affunlabeled
Wiring diagrams of MAPK regulation by MEKK1, 2, and 3
Mark Uhlik, Amy N. Abell, Bruce D. Cuevas, Kazuhiro Nakamura, Gary L. Johnson
2004· review· en· Biochemistry and Cell Biology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
101
citations
afffundno abstractunlabeled
Targeting MAPK pathway in melanoma therapy
Yabin Cheng, Guohong Zhang, Gang Li
2013· review· en· Cancer and Metastasis Reviews· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
96
citations

How this was built: Screen · Findings · About